Allosteric modifiers of hemoglobin. 2. Crystallographically determined binding sites and hydrophobic binding/interaction analysis of novel hemoglobin oxygen effectors.
The protein-bound conformations of six new allosteric effectors similar to bezafibrate that markedly decrease the oxygen affinity of hemoglobin have been determined by X-ray crystallography. Comparisons are made with the bound conformations of three urea analogues reported by Lalezari, Perutz, and co-workers. All six new molecules bind at the same site previously observed for bezafibrate and exhibit a wide range of allosteric activity. Unlike the urea derivatives, which show two binding sites for the most potent derivatives, only one of the six new molecules (one with moderate allosteric activity) exhibits a second binding site. A new computer program, HINT (hydrophobic interactions), has been created and utilized to identify the major interactions between small molecules and the protein. The three strongest interactions identified by HINT involve Arg 141 alpha with the acid of the analogues, Lys 99 alpha with the bridging amide carbonyl, and the amide NH of the side chain of Asn 108 beta with the halogenated aromatic ring.
Wireko
F C
FC
Department of Medicinal Chemistry, Medical College of Virginia/Virginia Commonwealth University, Richmond 23298-0581.
Kellogg
G E
GE
Abraham
D J
DJ
D000495:Allosteric Site / Q000187:drug effects*; D001629:Bezafibrate / Q000378:metabolism; D055598:Chemical Phenomena; D002621:Chemistry; D003201:Computers; D004347:Drug Interactions; D006454:Hemoglobins / Q000378:metabolism*; D006801:Humans; D010100:Oxygen / Q000378:metabolism*; D013237:Stereoisomerism; D013329:Structure-Activity Relationship; D014508:Urea / Q000031:analogs & derivatives; D014961:X-Ray Diffraction
D006454:Hemoglobins; D014508:Urea; C100003:deoxyhemoglobin; D010100:Oxygen; D001629:Bezafibrate